TerraForm Power Reports Third Quarter 2017 Results
Nov 09, 2017 22:30 pm UTC| Business
BETHESDA, Md., Nov. 09, 2017 -- TerraForm Power, Inc. (Nasdaq:TERP) (“TerraForm Power”) today reported financial results for the three months ended September 30, 2017. “We are very excited about the prospects for...
Myriad Genetics to Present at the 2017 Jefferies London Healthcare Conference
Nov 09, 2017 22:30 pm UTC| Business
SALT LAKE CITY, Nov. 09, 2017 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at the...
RGS Energy Reports Third Quarter 2017 Results
Nov 09, 2017 22:25 pm UTC| Business
DENVER, Nov. 09, 2017 -- RGS Energy (NASDAQ:RGSE), the nation’s original solar company since 1978, reported results for its third quarter ended September 30, 2017. Financial Summary (000’s omitted) Q3...
American Health Council Calls for Support to Prevent Closure of Children’s Psychiatric Center
Nov 09, 2017 22:24 pm UTC| Business
NEW YORK, Nov. 09, 2017 -- Currently on the state’s closure list, the Western New York Children’s Psychiatric Center (WNYCPC) is facing a possible shutdown with plans for absorption by the Buffalo Psychiatric Center...
Intrusion Inc. Announces Financial Release Date and Conference Call
Nov 09, 2017 22:18 pm UTC| Business
RICHARDSON, Texas, Nov. 09, 2017 -- Intrusion Inc. (OTCQB:INTZ), (“Intrusion”) will announce third quarter 2017 financial results on Monday, November 13, 2017. The press release will be published over the wire services...
U.S. Geothermal Inc. Reports Third Quarter 2017 Results and Updates 2017 Guidance
Nov 09, 2017 22:07 pm UTC| Business
Highlights 20th consecutive quarter of positive Cash Flow from Operations and EBITDAAchieved increased generation at Raft River; expected to provide approximately $1 million increase in revenue in 2018Completed...
Immunovaccine Announces Third Quarter 2017 Financial Results
Nov 09, 2017 22:05 pm UTC| Business
HALIFAX, Nova Scotia, Nov. 09, 2017 -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today released its financial and operational results for the third quarter ended September 30,...